Wed, 13 May 2015 | DIVISION SALE
Delivery company Whistl, previously TNT Post, is reviewing its options as its financial problems head towards crisis point.
The business was in talks with LDC, a division of Lloyd's Banking Group, regarding significant investment to back its expansion plans. However, LDC pulled out of the deal in April, stating ongoing changes and complex regulatory conditions as reasons why it won't be investing.
The decision has left Whistl without the funding needed to support its plans for expansion of door-to-door services and prompted the company to conduct an “extensive review” of the viability and potential for the extension of its services.
A statement from the firm read: “To stem the losses from the operations we have taken the difficult decision to suspend the current E2E service during the review process and all mail will now be delivered through our long-standing downstream access service until we have concluded the review.
"As part of this extensive review, we will begin consultations with the relevant employees who are affected by the suspension of the E2E service, and with their union representatives, with a view to identifying and exploring viable proposals to secure the continuation of this service."
The company has already suspended its door-to-door delivery services in London, Liverpool and Manchester and some 2,000 jobs are thought to be at risk across the business as it reviews its future.
Whistl's directors are currently reviewing their options in light of the withdrawal of investment and the changing landscape across the sector to ascertain the best way forward.
View the latest businesses for sale.
This unique and renowned freehold bar and restaurant in the heart of York City Centre offers over 250 covers across its spacious interior, pavement seating, and a rare rooftop terrace.
FREEHOLD
A well established and strongly profitable engineering business, located in the Midlands. The company will be an attractive acquisition for both a larger trade buyer and also those looking for a stable engineering business.
This European pharmacy manufacturer specialises in providing custom clinical trial batches for leading pharmacy companies across the continent, playing a crucial role in their R&D efforts.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.